Daniel Orenstein - 06 Jun 2022 Form 4 Insider Report for Health Catalyst, Inc. (HCAT)

Role
General Counsel
Signature
/s/ Daniel Orenstein
Issuer symbol
HCAT
Transactions as of
06 Jun 2022
Transactions value $
-$42,140
Form type
4
Filing time
08 Jun 2022, 16:02:41 UTC
Previous filing
03 Jun 2022
Next filing
06 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCAT Common Stock Sale -$42,139 -2,838 -2.66% $14.85 103,671 06 Jun 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person in accordance with Rule 10b5-1.
F2 Represents the weighted average sale price of the shares sold ranging from $14.62 to $15.18 per share, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.